Mary Jean Klein

1.1k total citations
15 papers, 819 citations indexed

About

Mary Jean Klein is a scholar working on Oncology, Genetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Mary Jean Klein has authored 15 papers receiving a total of 819 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Genetics and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Mary Jean Klein's work include Estrogen and related hormone effects (6 papers), Breast Cancer Treatment Studies (4 papers) and Cancer Risks and Factors (3 papers). Mary Jean Klein is often cited by papers focused on Estrogen and related hormone effects (6 papers), Breast Cancer Treatment Studies (4 papers) and Cancer Risks and Factors (3 papers). Mary Jean Klein collaborates with scholars based in United States. Mary Jean Klein's co-authors include Rena Vassilopoulou‐Sellin, Richard L. Theriault, Pamela N. Schultz, Lina Asmar, Rena V. Sellin, Charles Stava, Martha L. Beck, Moody D. Wharam, Harold M. Maurer and Ruth Heyn and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and PEDIATRICS.

In The Last Decade

Mary Jean Klein

15 papers receiving 781 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Jean Klein United States 13 353 277 240 220 161 15 819
Valentina Elisabetta Bounous Italy 18 278 0.8× 199 0.7× 176 0.7× 160 0.7× 123 0.8× 43 858
Esther Alfandary Israel 9 209 0.6× 172 0.6× 65 0.3× 274 1.2× 192 1.2× 11 1.2k
Patrizia Matarazzo Italy 21 162 0.5× 342 1.2× 207 0.9× 275 1.3× 233 1.4× 73 1.2k
Dave Winter United Kingdom 11 196 0.6× 289 1.0× 342 1.4× 274 1.2× 164 1.0× 12 1.2k
Peter Vorwerk Germany 23 200 0.6× 430 1.6× 93 0.4× 148 0.7× 361 2.2× 53 1.3k
Robert D. Tiegs United States 18 635 1.8× 252 0.9× 139 0.6× 171 0.8× 172 1.1× 27 1.2k
Lynda E. Polgreen United States 20 239 0.7× 81 0.3× 158 0.7× 111 0.5× 91 0.6× 71 1.2k
S M Shalet United Kingdom 15 340 1.0× 796 2.9× 185 0.8× 96 0.4× 199 1.2× 36 1.7k
H. Rao Gattamaneni United Kingdom 23 230 0.7× 531 1.9× 122 0.5× 292 1.3× 298 1.9× 40 1.9k
P. Cohen United States 12 162 0.5× 282 1.0× 55 0.2× 422 1.9× 303 1.9× 23 868

Countries citing papers authored by Mary Jean Klein

Since Specialization
Citations

This map shows the geographic impact of Mary Jean Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Jean Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Jean Klein more than expected).

Fields of papers citing papers by Mary Jean Klein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Jean Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Jean Klein. The network helps show where Mary Jean Klein may publish in the future.

Co-authorship network of co-authors of Mary Jean Klein

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Jean Klein. A scholar is included among the top collaborators of Mary Jean Klein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Jean Klein. Mary Jean Klein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Mrózek, Ewa, Richard T. Kloos, Matthew D. Ringel, et al.. (2006). Phase II Study of Celecoxib in Metastatic Differentiated Thyroid Carcinoma. The Journal of Clinical Endocrinology & Metabolism. 91(6). 2201–2204. 43 indexed citations
2.
Schultz, Pamela N., Mary Jean Klein, Martha L. Beck, Charles Stava, & Rena V. Sellin. (2005). Breast cancer: relationship between menopausal symptoms, physiologic health effects of cancer treatment and physical constraints on quality of life in long‐term survivors. Journal of Clinical Nursing. 14(2). 204–211. 105 indexed citations
3.
Vassilopoulou‐Sellin, Rena & Mary Jean Klein. (2002). Health Care Priorities for Menopausal Women With a History of Breast Cancer. Southern Medical Journal. 95(11). 1269–1275. 1 indexed citations
4.
Vassilopoulou‐Sellin, Rena, Deborah S. Cohen, Gabriel N. Hortobágyi, et al.. (2002). Estrogen replacement therapy for menopausal women with a history of breast carcinoma. Cancer. 95(9). 1817–1826. 38 indexed citations
5.
Fernandes, J., Mary Jean Klein, Joann L. Ater, John F. Kuttesch, & Rena Vassilopoulou‐Sellin. (2002). Triiodothyronine supplementation for hypothalamic obesity. Metabolism. 51(11). 1381–1383. 29 indexed citations
6.
Sekhar, Ravi, Steven J. Culbert, W. Keith Hoots, et al.. (2001). Severe Osteopenia in a Young Boy With Kostmann's Congenital Neutropenia Treated With Granulocyte Colony-Stimulating Factor: Suggested Therapeutic Approach. PEDIATRICS. 108(3). e54–e54. 20 indexed citations
7.
Raney, R. Beverly, J Kollath, Rena Vassilopoulou‐Sellin, et al.. (2000). Late effects of therapy in 94 patients with localized rhabdomyosarcoma of the orbit: Report from the Intergroup Rhabdomyosarcoma Study (IRS)-III, 1984-1991. Medical and Pediatric Oncology. 34(6). 413–420. 86 indexed citations
8.
Vassilopoulou‐Sellin, Rena, et al.. (2000). Growth hormone deficiency in children with neurofibromatosis type 1 without suprasellar lesions. Pediatric Neurology. 22(5). 355–358. 23 indexed citations
9.
Raney, R. Beverly, Lina Asmar, Rena Vassilopoulou‐Sellin, et al.. (1999). Late complications of therapy in 213 children with localized, nonorbital soft-tissue sarcoma of the head and neck: A descriptive report from the Intergroup Rhabdomyosarcoma Studies (IRS)-II and - III. Medical and Pediatric Oncology. 33(4). 362–371. 127 indexed citations
10.
Vassilopoulou‐Sellin, Rena, Lina Asmar, Gabriel N. Hortobágyi, et al.. (1999). Estrogen Replacement Therapy After Localized Breast Cancer: Clinical Outcome of 319 Women Followed Prospectively. Journal of Clinical Oncology. 17(5). 1482–1482. 82 indexed citations
11.
Vassilopoulou‐Sellin, Rena, et al.. (1999). Osteopenia in young adult survivors of childhood cancer. Medical and Pediatric Oncology. 32(4). 272–278. 75 indexed citations
12.
Vassilopoulou‐Sellin, Rena, Richard L. Theriault, & Mary Jean Klein. (1997). Estrogen Replacement Therapy in Women with Prior Diagnosis and Treatment for Breast Cancer. Gynecologic Oncology. 65(1). 89–93. 74 indexed citations
13.
Vassilopoulou‐Sellin, Rena, Richard L. Theriault, & Mary Jean Klein. (1997). Estrogen Replacement Therapy in Women With Prior Diagnosis and Treatment for Breast Cancer. Obstetrical & Gynecological Survey. 52(8). 483–484. 10 indexed citations
14.
Klein, Mary Jean, et al.. (1996). Estrogen replacement therapy after treatment for localized breast carcinoma: Patient responses and opinions. Cancer. 78(5). 1043–1048. 22 indexed citations
15.
Vassilopoulou‐Sellin, Rena, Mary Jean Klein, Pamela N. Schultz, et al.. (1993). Impact of adjuvant mitotane on the clinical course of patients with adrenocortical cancer. Cancer. 71(10). 3119–3123. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026